NEW YORK--(BUSINESS WIRE)--Lowenstein Sandler LLP added strength to its exceptional White Collar Criminal Defense Practice with another outstanding addition: Paul Weissman joins the firm as senior counsel with more than 30 years of white collar and pharmaceutical industry litigation experience. He will serve clients from the firm’s offices nationwide.
Mr. Weissman was an Assistant U.S. Attorney in Newark from 1982 to 2002. Serving as Deputy Chief of the Fraud Division and Chief of the Financial Institution Fraud Unit, he conducted and/or supervised the prosecution of numerous high-profile securities, tax, bank and health care fraud cases. He then served for more than a dozen years in the pharmaceutical industry, first as Schering-Plough’s Staff Vice President for Compliance and then as a Managing Counsel at Merck, after it merged with Schering-Plough.
With his extensive, high-level prosecutorial and corporate experience, Mr. Weissman offers clients a truly multidimensional perspective. He understands first-hand how the government investigates and prosecutes fraud, and how corporations must manage investigations, regulatory compliance and litigation. Having managed teams of outside lawyers at Merck and Schering-Plough, he understands how clients want to be served.
Lowenstein Sandler’s long-term strategy is to grow by doubling down on core areas of strength that match the marketplace’s growing demand for certain legal services. Within the past two years, the firm has added to its roster of widely respected white collar defense attorneys several notable figures. In addition to Mr. Weissman, the firm has welcomed Matthew Boxer, former Comptroller for the State of New Jersey; Shavar Jeffries, former Special Counsel to the New Jersey Attorney General; and Maureen Ruane, former Chief of the Healthcare and Government Fraud Unit of the U.S. Attorney’s Office in Newark.
Gary Wingens, Lowenstein Sandler Chairman and Managing Partner, said, “Paul is a great fit per our long-term strategic plan. His distinguished background as an Assistant US Attorney and counsel to major pharmaceutical companies will add new dimensions to our core white collar practice as well as our corporate life sciences team. He understands business and possesses empathy for clients that springs from first-hand experience. And he is a genuine person who cares for his peers. We are excited to welcome him to the firm.”
Michael Himmel, Chair of the White Collar Criminal Defense Practice, said, “The health care industry has been beset by an increasing number of investigations of its conduct, from states’ attorneys general to US Attorneys to federal regulatory agencies. We’re seeing increased demand for our services, as health care providers are now just as open to scrutiny as manufacturers. With his experience in government and on the corporate side, Paul will be a valuable asset to our clients and a fantastic addition to our team.”
Mr. Weissman said, “Lowenstein Sandler offers exactly what I was looking for in private practice: the scale and depth to serve the largest clients at a manageable size that supports a collegial environment and strong personal relationships with clients and fellow attorneys. The white collar defense practice’s reputation is first-rate, and I look forward to making a contribution to the firm and its clients.”
Paul earned his J.D., cum laude, from Harvard Law School, and his A.B., magna cum laude, Phi Beta Kappa, from Harvard College. Prior to law school, he was a Ph.D. student in history at Harvard University.
About Lowenstein Sandler
Lowenstein Sandler is a leading national law firm. Our 300 lawyers in New York, Washington, DC, New Jersey and California immerse themselves in our clients' industries in order to deeply understand their businesses. We are characterized by our passion for our clients' success, our commitment to our people, and our pro bono and public interest work in the communities that we serve. For more information, please visit www.lowenstein.com.
